Nathan K Evanson, MD, PhD

Nathan K. Evanson, MD PhD, is originally from Alberta, Canada. He obtained his bachelor's degree in biochemistry and nutritional science from Brigham Young University and went on to train in the physician scientist training program at the University of Cincinnati College of Medicine. He completed a combined residency program in pediatrics and physical medicine and rehabilitation, then joined the Division of Pediatric Physical Medicine and Rehabilitation at Cincinnati Children’s. He runs the Brain Recovery After Injury (BRAIN) clinic in the division, as well as doing basic research into recovery from traumatic brain injury.
Dr. Evanson's research interests include traumatic optic nerve injury in a mouse model of traumatic brain injury and metabolic dysregulation/metabolomics of chronic brain injury.
 

Bachelor's Degree: Brigham Young University Provo, UT, 2002 (Biochemistry and Nutritional Science)

Master's Degree: University of Cincinnati Cincinnati, OH, 2010

Doctoral Degree: University of Cincinnati Cincinnati, OH, 2010 (Neuroscience)

Residency: Cincinnati Children's Hospital Medical Center Cincinnati, OH, 2015 (Dual: Pediatrics and Physical Medicine and Rehabilitation)

Clinical practice includes pediatric acquired brain injury, which consists primarily of traumatic brain injury, but also includes other mechanisms of injury including hypoxic injuries, inflammatory and infectious injuries, drowning, and other mechanisms. 
Research interests primarily include animal models for studying traumatic brain injury recovery, and metabolism/metabolomics of chronic brain injury. 

07-2015 -To Present Assistant Professor, Clinical Pediatrics, division of pediatric rehabilitation, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Peer Reviewed Publications

Chandrasekharan N.;Dai H.;Roos K.;Evanson N.;Tomsik J.;Elton T.;Simmons D.  (10-15-2002). COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: . Proceedings of the National Academy of Sciences of the United States of America, 99 (21) , 13926-13931More Information

Evanson, N. K.; Paulson, A. L.; Kurowski, B. G.  (2016). A Narrative Review of Pharmacologic and Non-pharmacologic Interventions for Disorders of Consciousness Following Brain Injury in the Pediatric Population. Curr Phys Med Rehabil Rep, 4 (1 ) , 56-70

Kasckow J.;Segar T.;Xiao C.;Furay A.;Evanson N.;Ostrander M.;Herman J.  (07-01-2005). Stability of neuroendocrine and behavioral responsiveness in aging Fischer 344/Brown-Norway hybrid r. Endocrinology, 146 (7) , 3105-3112More Information

Choi D.;Furay A.;Evanson N.;Ostrander M.;Ulrich-Lai Y.;Herman J.  (02-21-2007). Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic-pituitary-adrena. Journal of Neuroscience, 27 (8) , 2025-2034More Information

Choi D.;Evanson N.;Furay A.;Ulrich-Lai Y.;Ostrander M.;Herman J.  (02-01-2008). The anteroventral bed nucleus of the stria terminalis differentially regulates hypothalamic-pituitar. Endocrinology, 149 (2) , 818-826More Information

Choi D.;Furay A.;Evanson N.;Ulrich-Lai Y.;Nguyen M.;Ostrander M.;Herman J.  (06-01-2008). The role of the posterior medial bed nucleus of the stria terminalis in modulating hypothalamic-pitu. Psychoneuroendocrinology, 33 (5) , 659-669More Information

Evanson N.;Van Hooren D.;Herman J.  (10-01-2009). GluR5-mediated glutamate signaling regulates hypothalamo-pituitary-adrenocortical stress responses a. Psychoneuroendocrinology, 34 (9) , 1370-1379More Information

Evanson N.;Herman J.;Sakai R.;Krause E.  (08-01-2010). Nongenomic actions of adrenal steroids in the central nervous system. Journal of Neuroendocrinology, 22 (8) , 846-861More Information

Evanson N.;Tasker J.;Hill M.;Hillard C.;Herman J.  (01-01-2010). Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology, 151 (10) , 4811-4819More Information

Ulrich-Lai Y.;Christiansen A.;Ostrander M.;Jones A.;Jones K.;Choi D.;Krause E.;Evanson N.;Furay A.;Davis J.;Solomon M.;De Kloet A.;Tamashiro K.;Sakai R.;Seeley R.;Woods S.;Herman J.  (11-23-2010). Pleasurable behaviors reduce stress via brain reward pathways. Proceedings of the National Academy of Sciences of the United States of America, 107 (47) , 20529-20534More Information

Krause E.;de Kloet A.;Flak J.;Smeltzer M.;Solomon M.;Evanson N.;Woods S.;Sakai R.;Herman J.  (04-06-2011). Hydration state controls stress responsiveness and social behaviors. Journal of Neuroscience, 31 (14) , 5470-5476More Information

Evanson N.;Herman J.  (10-05-2015). Metabotropic glutamate receptor-mediated signaling dampens the HPA axis response to restraint stress. Physiology and Behavior, 150, 2-7More Information

Evanson N.K.  (12-01-2011). LY382884. xPharm: The Comprehensive Pharmacology Reference, 1-4More Information

Evanson N.K.  (12-01-2011). Fenbufen. xPharm: The Comprehensive Pharmacology Reference, 1-4More Information

Evanson N.K.  (12-01-2011). ATPA. xPharm: The Comprehensive Pharmacology Reference, 1-5More Information

Evanson N.K.  (12-01-2011). Diflunisal. xPharm: The Comprehensive Pharmacology Reference, 1-5More Information

Evanson N.K.  (12-01-2011). Flufenamic acid. xPharm: The Comprehensive Pharmacology Reference, 1-6More Information

Evanson N.K.  (12-01-2011). Trisalicylate. xPharm: The Comprehensive Pharmacology Reference, 1-4More Information

Evanson N.K.  (12-01-2011). Tolfenamic acid. xPharm: The Comprehensive Pharmacology Reference, 1-4More Information

Evanson N.K.  (12-01-2011). Dipyrone. xPharm: The Comprehensive Pharmacology Reference, 1-7More Information

Evanson N.K.  (12-01-2011). Diclofenac. xPharm: The Comprehensive Pharmacology Reference, 1-7More Information

Evanson N.K.  (12-01-2011). Meloxicam. xPharm: The Comprehensive Pharmacology Reference, 1-6More Information

Herman J.P.;Figueiredo H.F.;Mueller N.K.;Ostrander M.M.;Zhang R.;Tauchi M.;Choi D.C.;Furay A.R.;Evanson N.K.;Nelson E.B.;Ulrich-Lai Y.M.  (12-01-2007). Neurochemical systems regulating the hypothalamo-pituitary-adrenocortical axis. Handbook of Neurochemistry and Molecular Neurobiology: Behavioral Neurochemistry, Neuroendocrinology and Molecular Neurobiology, 513-569More Information

Evanson, Nathan K; Paulson, Andrea L; Kurowski, Brad G  (2016). A Narrative Review of Pharmacologic and Non-pharmacologic Interventions for Disorders of Consciousness Following Brain Injury in the Pediatric Population. Current physical medicine and rehabilitation reports, 4 (1) , 56-70

Evanson, Nathan K; Herman, James P  (2015). Metabotropic glutamate receptor-mediated signaling dampens the HPA axis response to restraint stress. Physiology & behavior, 150, 2-7More Information

Evanson, Nathan K; Herman, James PRole of Paraventricular Nucleus Glutamate Signaling in Regulation of HPA Axis Stress Responses. Interdisciplinary information sciences, 21 (3) , 253-260More Information

Evanson, Nathan K; Tasker, Jeffrey G; Hill, Matthew N; Hillard, Cecilia J; Herman, James P  (2010). Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology, 151 (10) , 4811-9More Information

Evanson, N K; Herman, J P; Sakai, R R; Krause, E G  (2010). Nongenomic actions of adrenal steroids in the central nervous system. Journal of neuroendocrinology, 22 (8) , 846-61More Information

Evanson, Nathan K; Van Hooren, Daniella C; Herman, James P  (2009). GluR5-mediated glutamate signaling regulates hypothalamo-pituitary-adrenocortical stress responses at the paraventricular nucleus and median eminence. Psychoneuroendocrinology, 34 (9) , 1370-9More Information

Evanson, Nathan K; Guilhaume-Correa, Fernanda; Herman, James P; Goodman, Michael D  (2018). Optic tract injury after closed head traumatic brain injury in mice: A model of indirect traumatic optic neuropathy. PloS one, 13 (5) , e0197346More Information